maprotiline has been researched along with Anorexia Nervosa in 2 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faltus, F | 2 |
| Janecková, E | 2 |
| Papezová, H | 1 |
2 other studies available for maprotiline and Anorexia Nervosa
| Article | Year |
|---|---|
Maintenance therapy with levoprotiline in anorexia nervosa and bulimia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Body Weight; Bulimia Nervosa; | 1991 |
Levoprotiline--function regulator of food and satiety centres?
Topics: Adolescent; Adult; Anorexia Nervosa; Anthracenes; Antidepressive Agents; Bulimia; Dibenzothiepins; D | 1989 |